All Industries

Top Biotech Companies

3,959 Biotech companies, sorted by total funding raised.

Perfect Day

Sustainable dairy protein from precision fermentation

Berkeley, United States51–200Biotech
Series E·$787.7M·Jan 2024
XtalPiIPO

AI and quantum physics-powered drug discovery platform accelerating pharmaceutical R&D through cr...

Beijing, China1001–5000Biotech, Artificial Intelligence
Series D·$785.1M·Jan 2021
TheranosClosed

Blood testing technology company claiming miniaturized diagnostics

Palo Alto, United States501–1000Biotech, Healthcare
Venture Round·$750.0M·Jun 2014
Enveda Biosciences

Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...

Boulder, United States201–500Artificial Intelligence, Biotech
Series D·$740.0M·Sep 2025
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate Round·$730.0M·Dec 2025
EQRxClosed

Developing new medicines with the goal of expanding global access for patients

Cambridge, United States51–200Healthcare, Biotech
Series B·$700.0M·Jan 2021
Odyssey Therapeutics

Clinical-stage biopharmaceutical company developing small molecule and protein therapeutics for a...

Boston, United States51–200Biotech, Healthcare
Series D·$700.0M·Sep 2025
ImmunicIPO

Late-stage biotechnology company developing novel selective oral immunology therapies for chronic...

New York City, United StatesBiotech, Healthcare
Private Equity·$694.9M·Feb 2026
FogPharma

Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...

Cambridge, United States51–200Biotech, Drug Discovery
Series F·$694.0M·Jan 2025
Generate BiomedicinesIPO

AI-powered generative biology platform creating novel protein therapeutics across antibodies, pep...

Cambridge, United States201–500Artificial Intelligence, Biotech
Corporate Round·$693.0M·Dec 2024
Gossamer BioIPO

Biopharmaceutical company developing seralutinib for the treatment of pulmonary arterial hyperten...

San Diego, United States51–200Biotech, Healthcare
Private Equity·$662.0M·Jul 2023
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series B·$650.0M·Oct 2025
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series D·$648.3M·Jul 2024
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private Equity·$647.0M·Feb 2026
Solugen

Decarbonizing the chemicals industry.

Houston, United States51–200Biotech, Climate Tech
Venture Round·$645.7M·Mar 2026
Celularity

Celularity is a biotechnology company developing off-the-shelf placental-derived allogeneic cell ...

Florham Park, United States51–200Biotech, Healthcare
Extension Round·$645.0M·Jan 2021
insitro

High-quality perturbational data generation and AI to discover new targets and enable drug discov...

South San Francisco, United States201–500Artificial Intelligence, Healthcare
Series C·$643.0M·Mar 2021
Insilico MedicineIPO

AI-driven drug discovery company using generative AI and deep learning to design novel drug candi...

Hong Kong, Hong Kong201–500Artificial Intelligence, Biotech
Series E·$632.8M·Mar 2026
Color

Population-scale health company delivering genetic testing, cancer screening, and virtual clinica...

Burlingame, United States501–1000Life Sciences, Biotech
Series E·$614.0M·Nov 2021
Cellares

Cell therapy manufacturing company building automated factories to accelerate cell therapy produc...

South San Francisco, United States51–200Biotech, Healthcare
Series D·$612.0M·Jan 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series B·$612.0M·Oct 2022
Century TherapeuticsIPO

Century Therapeutics develops allogeneic iPSC-derived NK and T cell therapies for cancer and auto...

Philadelphia, United States51–200Biotech, Healthcare
Corporate Round·$605.0M·Jan 2026
Edgewise TherapeuticsIPO

Clinical-stage biopharmaceutical company developing oral therapies for serious skeletal and cardi...

Boulder, United States51–200Biotech, Healthcare
Growth Equity·$585.0M·Apr 2025
ImmunovantIPO

Clinical-stage biopharmaceutical company developing FcRn inhibitor therapies for IgG-mediated aut...

New York, United States51–200Biotech, Healthcare
Angel·$585.0M·Oct 2019
UPSIDE Foods

A pioneer in the cell-based meat industry.

Berkeley, United States201–500Biotech, Food Tech
Series C·$583.0M·Apr 2022